// App-Quantinova.ai

PD2-07 : 10-year follow-up and biomarker discovery for adjuvant endocrine therapy; results of the TEAM trial

Researchers

Presenter

  • EJ Blok

Principal Investigators

  • MGM Derks

  • PJK Kuppen

  • EM Meershoek-Klein Kranenbarg

  • CC Engels

  • G-J Liefers

  • H Putter

  • CM Seynaeve

  • JR Kroep

  • JWR Nortier

  • DW Rea

  • A Hasenburg

  • CJ Markopoulos

  • R Paridaens

  • JMS Bartlett

  • CJH van de Velde

Medical Centers

  • Athens University Medical School, Athens, Greece

  • University Hospital Marburg, Marburg, Germany

  • Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • University of Birmingham, Birmingham, United Kingdom

  • Leiden University Medical Centre, Leiden, Netherlands

  • Erasmus University Medical Center, Rotterdam, Netherlands

Locations

  • Canada

  • Greece

  • Netherlands

  • Germany

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Alpha thalassemia mental retardation X-linked protein

  • Cluster of differentiation 8A

  • Human leukocyte antigen G

Drug/Treatment

  • Exemestane

  • Tamoxifen

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved